Skip to content
healthcare.dev
Get a free key

Lisdexamfetamine Dimesylate

NDC 0054-0374, lisdexamfetamine dimesylate, capsule, from Hikma Pharmaceuticals USA Inc..

Product NDC
0054-0374
Status
Listed
Labeler
Hikma Pharmaceuticals USA Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202827
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0374 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LISDEXAMFETAMINE DIMESYLATE60 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

Package NDCNDC-11Package
0054-0374-2500054037425100 CAPSULE in 1 BOTTLE (0054-0374-25)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6740a621-9bec-4178-a4fc-a3fc89f34e0a

  • NADAC price for package 00054037425

    GET /v1/drugs/nadac/00054037425

Use it

Look up 0054-0374 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0374 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0054-0374. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.